Search

everythinglearnresearchcommunity

for

Search:↓

Patients with alopecia areata face challenges accessing Janus kinase inhibitors, but some see positive results.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Certain gene variations may increase the risk and severity of alopecia areata.

Alefacept does not effectively treat severe alopecia areata.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Ritlecitinib is safe and may effectively treat alopecia areata.

Upadacitinib effectively treats severe alopecia areata and is safe.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

A new drug, abrocitinib, helped a child with severe hair loss regrow hair.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Both treatments improved alopecia areata, but methotrexate caused more skin darkening, while triamcinolone caused skin lightening and thinning.

A new mix of anthralin and calcipotriene might help treat severe hair loss.

The new assay can track and measure melanosome transfer between skin cells, confirming filopodia's role in this process.